Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

More impressive data from Bluebird’s gene therapy in thalassemia and sickle cell disease

Cell and gene therapy specialist Bluebird going head-to-head with partner Celgene

- PMLiVE

UK firm Nightstar bags FDA fast-track status for gene therapy

Its choroideremia disease candidate gets RMAT designation

- PMLiVE

British Business Bank sets up £2.5bn fund for ‘unicorn’ firms

UK government says the private sector will bring in another £5bn in investments

- PMLiVE

Anthill Agency launch digital-focused academy

Partners with Actando’s PharmAcademy to boost pharma’s digital skills

- PMLiVE

Eisai to tackle dementia in new US research facility

Aims to introduce a new compound into the clinic by 2020

- PMLiVE

AMICULUM launch specialist agency

Seques will be led by Jenny Szkolar and Patricia Jones

- PMLiVE

Sage surges after depression drug gets rapid path to approval

Will be able to file a marketing application based on its phase II trial

Weekly comms appointments

Publicis Resolute, Road and W2O all add to their teams

- PMLiVE

UK, Germany back routine use of J&J’s Tremfya

The IL-23 inhibitor is currently being assessed in other EU countries

- PMLiVE

Revenue down the back of the beanbag

How to engage with employees to create a sophisticated strategy

Australian Flu and the dilemma of naming diseases

During the winter of 2017-2018 not a day passed when the Australian flu was not mentioned by the UK press. The British media turned talking about Australian flu into an...

Say Communications

- PMLiVE

Health Unlimited bolsters PR team

Appoints Ann Bartling as PR practice lead

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links